Valuation: AtriCure, Inc.

Market Cap 3.34B 2.97B 2.72B 2.48B 4.67B 315B 4.79B 32.67B 13.07B 167B 12.53B 12.26B 527B P/E 2026 *
574x
P/E 2027 * 148x
Enterprise Value 3.17B 2.82B 2.58B 2.35B 4.43B 299B 4.55B 31.03B 12.41B 159B 11.89B 11.64B 500B EV / Sales 2026 *
5.23x
EV / Sales 2027 * 4.57x
Free-Float
96.24%
Yield 2026 *
-
Yield 2027 * -
1 day-6.49%
1 week-0.23%
Current month+0.05%
1 month+11.14%
3 months+57.13%
6 months+112.93%
Current year+54.90%
1 week 58
Extreme 58
66.02
1 month 51.63
Extreme 51.63
66.02
Current year 25.36
Extreme 25.36
66.02
1 year 25.36
Extreme 25.36
66.02
3 years 18.94
Extreme 18.94
66.02
5 years 18.94
Extreme 18.94
87.52
10 years 14.78
Extreme 14.78
89.18
Manager TitleAgeSince
Chief Executive Officer 55 2012-11-01
Director of Finance/CFO 48 2014-06-30
Chief Tech/Sci/R&D Officer 59 2017-07-17
Director TitleAgeSince
Director/Board Member 55 2012-11-01
Director/Board Member 64 2013-03-10
Director/Board Member 75 2016-11-09
Date Insider Type Main position Quantity % Market Cap. Importance
9/23/26 Sell

Chief Technology Officer

-4,519 0.0089%
9/11/26 Sell

Director

-5,313 0.0104%
9/8/26 Sell

Chief Technology Officer

-3,657 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-6.49%-0.23%+87.11%+65.71% 3.33B
-1.65%+10.68%-9.70%+18.53% 200B
-0.11%+10.61%+15.95%+44.49% 128B
-1.35%+10.22%-7.59%+21.31% 129B
+1.51%+8.02%-39.33%+10.16% 97.53B
-4.05%+4.73%-1.41%+74.04% 67.55B
+2.08%+9.42%+19.28%-17.52% 56.98B
-3.99%+19.15%-7.12%+56.23% 55.04B
-1.39%-8.86%-4.24%+57.30% 51.24B
-0.79%+8.92%+3.39%-6.33% 37.43B
Average -1.62%+8.63%+5.63%+32.39% 82.68B
Weighted average by Cap. -1.05%+9.77%-4.71%+28.04%

Financials

2026 *2027 *
Net sales 606M 540M 494M 450M 848M 57.29B 871M 5.94B 2.37B 30.34B 2.28B 2.23B 95.74B 680M 606M 555M 505M 952M 64.3B 978M 6.66B 2.66B 34.05B 2.55B 2.5B 107B
Net income 6.51M 5.8M 5.3M 4.83M 9.1M 615M 9.35M 63.7M 25.47M 326M 24.42M 23.89M 1.03B 18.97M 16.91M 15.46M 14.08M 26.54M 1.79B 27.26M 186M 74.28M 949M 71.21M 69.68M 3B
Net Debt -168M -150M -137M -125M -235M -15.88B -241M -1.65B -658M -8.41B -631M -617M -26.53B -229M -204M -187M -170M -321M -21.65B -329M -2.24B -897M -11.46B -860M -841M -36.18B
Projected Income Statement - Annual - AtriCure, Inc.
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
26-11-05 US$61.28 -6.49% 978,400
26-11-04 US$65.53 +8.48% 1,335,732
26-11-03 US$60.41 +0.89% 1,606,810
26-11-02 US$59.88 -2.24% 1,122,932
26-10-30 US$61.25 -1.97% 967,355
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - AtriCure, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
65.53USD
Average target price
57.56USD
Spread / Average Target
-12.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AtriCure, Inc.
  1. Stock Market
  2. Stocks
  3. ATRC Stock